Sonic Healthcare Ltd

SHL: XASX (AUS)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
BTRLOCK|%Fy>RLOCK|n#qnrT

Sonic Healthcare Earnings: Shares Undervalued as Market Demands Faster Margin Turnaround

Sonic Healthcare's fiscal 2025 EBITDA rose 9% on 5% organic sales growth and underlying EBITDA margins expanding 40 basis points to 18%. Fiscal 2026 EBITDA guidance implies 8% growth at the midpoint in constant-currency, disappointing the market with shares down over 12%.

Sponsor Center